Motilal Oswal Buy Recommendations: 8 Best Stocks to Watch in June 2025
If you’re searching for the most trusted stock ideas this month, look no further than the latest Motilal Oswal buy recommendations for June 2025. Every month, Motilal Oswal’s research team highlights stocks with strong fundamentals, growth stories, and attractive return potential. Their June list features eight standout companies across banking, real estate, healthcare, and more, each with the potential to deliver double-digit gains. Let’s explore why these Motilal Oswal buy recommendations are making headlines and how they can help you build a winning portfolio.
1. State Bank of India (SBI): Steady Growth, Strong Balance Sheet
Motilal Oswal has a Buy call on SBI with a target price of ₹925, implying a 14% upside. India’s largest public sector bank continues to impress with robust business growth, tight control on bad loans, and a rock-solid balance sheet.
Despite a temporary dip in net interest margins, SBI’s management expects stability ahead, with credit costs likely to remain low thanks to prudent lending and healthy recoveries. With a projected 6% earnings CAGR through FY27 and a strong return on equity, SBI is well-positioned for the next phase of growth.
2. Adani Ports & SEZ: Transforming into a Transport Utility
Motilal Oswal’s target price for Adani Ports & SEZ is ₹1,700, offering a 19% upside. The company is on the cusp of a major transformation, with its logistics business expected to multiply fivefold by FY29.
By integrating logistics with ports, Adani Ports is evolving into a full-scale transport utility. The stock is attractively valued at 16x FY27E EV/EBITDA, and its aggressive expansion plans make it a compelling long-term play for investors seeking both growth and stability.
3. Apollo Hospitals: Digital Health & Diagnostics Drive Growth
Apollo Hospitals earns a Buy rating with a target price of ₹8,050, indicating a 17% upside. The company is set to benefit from improved productivity and a turnaround in its diagnostics and digital health businesses.
Motilal Oswal forecasts strong revenue and profit growth through FY27, with operational efficiency and new bed additions fueling future gains. Apollo’s focus on digital health and diagnostics positions it well for the next wave of healthcare innovation.
4. Prestige Estates Projects: Robust Pipeline, Re-Rating Potential
With a revised target price of ₹1,938 (up to 32% upside), Prestige Estates is in the spotlight. While FY25 bookings were below guidance due to approval delays, the outlook for FY26 is robust, supported by a healthy pipeline.
The company is making headway in both residential and commercial segments and unlocking value from its hospitality division. Motilal Oswal believes these factors could lead to a further re-rating and strong returns for investors.
5. IPCA Laboratories: Growth from Domestic & Export Formulations
IPCA Labs is rated Buy with a target price of ₹1,750 (17% upside). Despite a minor cut in earnings estimates, the brokerage remains positive, citing strong execution in domestic formulations and synergy benefits from the Unichem acquisition.
IPCA reported healthy sales growth and improved margins, with a positive outlook for both domestic and export businesses. The stock stands out for its consistency and future-ready pharma strategy.
6. Sobha: Land Bank & Project Pipeline Support Upside
Sobha receives a Buy call with a revised target of ₹1,778, implying a 24% upside. The company’s vast land reserves and recent fundraise support new project acquisitions and future launches.
Motilal Oswal values Sobha’s ongoing and upcoming projects highly, noting that its updated launch pipeline and monetization potential provide a solid foundation for future performance.
7. Lemon Tree Hotels: Occupancy Gains & Expansion Pipeline
Lemon Tree Hotels is rated Buy with a target of ₹200, indicating a 16% potential upside. After a strong FY25, the company is poised for further growth, supported by rising occupancy rates, higher room rates, and a robust expansion pipeline.
Motilal Oswal highlights the ramp-up of Aurika Mumbai, favorable demand-supply dynamics, and the company’s loyalty program as key drivers for continued momentum in the hospitality sector.
8. Spandana Sphoorty: Value Buy with Recovery Potential
Spandana Sphoorty gets a Buy call with a target of ₹340, translating to a 17% upside. While the company faced challenges in FY25—like lower disbursements and higher credit costs—Motilal Oswal sees improvement ahead.
They project an 18% AUM CAGR through FY27 and believe that even a hint of operational stability could spark a meaningful re-rating. At current valuations, Spandana offers a favorable entry point for patient investors.
Why These Stocks Stand Out Now
Motilal Oswal’s June 2025 picks are all about growth, transformation, and resilience. Whether it’s SBI’s steady performance, Adani Ports’ logistics leap, Apollo’s digital health push, or Lemon Tree’s hospitality gains, each stock has a clear story and a roadmap for value creation. The brokerage’s focus on strong fundamentals and future earnings potential makes these stocks worth watching for the month ahead.
How to Use These Recommendations
- Review your portfolio: See if these stocks fit your goals and risk appetite.
- Diversify: Don’t put all your money in one sector or stock.
- Stay updated: Follow company news, quarterly results, and sector trends.
- Invest for the long term: These picks are based on multi-year growth stories.
Final Thoughts
The start of June 2025 brings new opportunities for investors. With Motilal Oswal’s latest buy recommendations, you have a ready list of stocks with strong upside potential and solid fundamentals. Remember, smart investing is about staying informed, thinking long-term, and choosing quality over hype. Happy investing!
